High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia.

about

High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia.

Item

http://www.wikidata.org/entity/Q36640231

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@ast

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@en

type

Item

label

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@ast

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@en

prefLabel

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@ast

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@en

P1476

High expression of LMO2 predic ...... acute lymphoblastic leukemia.

@en

P2093

Eman M Abdsalam

http://www.w3.org/2001/XMLSchema#string

Mona M Taalab

http://www.w3.org/2001/XMLSchema#string

Omar E Hasan

http://www.w3.org/2001/XMLSchema#string

Omar H Elyamany

http://www.w3.org/2001/XMLSchema#string

Rabab M Aly

http://www.w3.org/2001/XMLSchema#string

P2860

TTG-2, a new gene encoding a cysteine-rich protein with the LIM motif, is overexpressed in acute T-cell leukaemia with the t(11;14)(p13;q11)

The rhombotin family of cysteine-rich LIM-domain oncogenes: distinct members are involved in T-cell translocations to human chromosomes 11p15 and 11p13

Structure of the leukemia oncogene LMO2: implications for the assembly of a hematopoietic transcription factor complex

Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling

The LIM domain: regulation by association

LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1

Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1

Genome-wide analysis of genetic alterations in acute lymphoblastic leukaemia

The transcription factor LMO2 is a robust marker of vascular endothelium and vascular neoplasms and selected other entities.

LMO2 expression reflects the different stages of blast maturation and genetic features in B-cell acute lymphoblastic leukemia and predicts clinical outcome.

P304

1917-1922

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2016.4127

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

291379259

http://www.w3.org/2001/XMLSchema#string

P698

26998100

http://www.w3.org/2001/XMLSchema#string

P932

4774442

http://www.w3.org/2001/XMLSchema#string